The nightly ledger

Stock catalysts from the latest SEC filings

Every 8-K, 10-Q and 10-K that AIR's companies filed on SEC EDGAR, and what each one changed in AIR's read. Material filings first, newest first — never ordered by price. For 8-K filing alerts, follow a company and turn on filing emails.

By event type: Acquisitions · Major contracts

Seven-day window, 2 weeks back · Material filings: 1629 · All filings: 1839

Material

Tuesday 3 Nov127 filings read · 127 material

  • 8-KFiled 3 Nov 2026All industries

    GLOBAL INDUSTRIAL CoGIC

    8-K · Item 2.02 — Results of operations

    Q3 2026 sales increased 10.2% to $389.5M; diluted EPS grew 33.3% to $0.64. Gross margin expanded to 35.7%. Board declared $0.28 regular dividend plus $1.00 special dividend. Strong cash position of $119.2M.

    Recognition: Balanced 60 → Balanced 63Gap Medium · 24 → High · 31

    More of the market is starting to notice.

    Progress is running ahead of attention.

    The price trend strengthened.

    More facts
    Momentum: Very strong
    Material
  • 8-KFiled 3 Nov 2026All industries

    Otter Tail CorpOTTR

    8-K · Item 2.02 — Results of operations

    Q3 2026 diluted EPS of $1.41 reported. Company affirmed midpoint of annual guidance ($3.89–$4.19) and narrowed range. Electric segment stable; Manufacturing improved; Plastics segment declined due to lower volumes and pricing pressure.

    Recognition: Balanced 60 → Balanced 54Value: Watch 36 → Balanced 46

    Market attention has faded.

    The shares became cheaper on AIR's value read.

    The price trend weakened.

    More facts
    Momentum: Balanced
    Material
  • 8-KFiled 3 Nov 2026All industries

    LGI Homes, Inc.LGIH

    8-K · Item 2.02 — Results of operations

    Q3 2026: LGI Homes delivered 1,222 home closings (+10.4% YoY), $437.5M revenue (+10.3%), and $24.6M net income (+24.8%). Gross margins expanded 40bps sequentially to 20.2%. Community count grew 7.1% to 151. Full-year guidance narrowed to 4,600–4,800 closings due to affordability headwinds.

    Gap Very high · 49 → Very high · 56

    Progress is running ahead of attention.

    The price trend strengthened.

    More facts
    Momentum: Watch
    Material
  • 8-KFiled 3 Nov 2026Software / SaaS

    Shopify Inc.SHOP

    8-K · Item 2.02 — Results of operations

    Shopify reported Q3 2026 revenue growth of 32% YoY to $3.74B, with free cash flow margin of 22% (up from 18% prior year). GMV reached $119.1B. Q4 2026 guidance projects low-thirties revenue growth and consistent FCF margin.

    Gap Low · 1 → Low · 5

    Progress is running ahead of attention.

    The price trend weakened.

    More facts
    Momentum: Balanced
    Material
  • 8-KFiled 3 Nov 2026All industries

    Rayonier Advanced Materials Inc.RYAM

    8-K · Item 2.02 — Results of operations

    Q3 2026: $229M net loss including $221M non-cash impairments. Temiscaming paperboard/pulp operations economically idled Oct 3 due to 50% U.S. tariffs on Canadian paperboard. Strategic review delayed to Q1 2027. HPC segment showed modest gains but overshadowed by Paperboard & HYP losses.

    No notable change in AIR's read.

    More facts
    Momentum: Watch
    Material
  • 8-KFiled 3 Nov 2026Software / SaaS

    Procore Technologies, Inc.PCOR

    8-K · Item 2.02 — Results of operations

    Q3 2026 revenue of $402M (+19% YoY) exceeded guidance high-end; non-GAAP operating margin 23%. Company raised full-year 2026 and 2027 revenue/margin guidance. GRR 95%, $100K+ ARR customers +14% YoY. DroneDeploy acquisition completed.

    Recognition: Strong 74 → Very strong 83Gap High · 34 → High · 26

    The gap narrowed — attention is catching up.

    The price trend strengthened.

    More facts
    Momentum: Strong
    Material
  • 8-KFiled 3 Nov 2026All industries

    Talen Energy CorpTLN

    8-K · Item 2.02 — Results of operations

    Q3 2026 Adjusted EBITDA of $669M and Free Cash Flow of $433M exceeded prior periods. Company reaffirmed 2026 guidance and introduced 2027 guidance showing ~26-27% growth. Upsized share repurchase program to $3.0B and announced $1.5B accelerated repurchase.

    Gap Very high · 74 → Very high · 79

    Progress is running ahead of attention.

    The price trend weakened.

    More facts
    Momentum: Watch
    Material
  • 8-KFiled 3 Nov 2026All industries

    Xenia Hotels & Resorts, Inc.XHR

    8-K · Item 2.02 — Results of operations

    Q3 2026 results significantly exceeded expectations. Adjusted EBITDAre grew 26.0% YoY to $53.2M; Adjusted FFO per share surged 56.5% to $0.36. Same-Property RevPAR +12.5%, occupancy +380bps. Full-year guidance raised: Adjusted EBITDAre +$8M, FFO/share +$0.09.

    Gap Low · 3 → Medium · 11

    Progress is running ahead of attention.

    The price trend strengthened.

    More facts
    Momentum: Very strong
    Material
  • 8-KFiled 3 Nov 2026All industries

    Bowhead Specialty Holdings Inc.BOW

    8-K · Item 2.02 — Results of operations

    Q3 2026: Gross written premiums grew 10.8% to $256.4M; adjusted net income up 16% to $18.4M ($0.54/share); adjusted ROE 15.9%. Digital segment expanded to 9% of premiums. Combined ratio improved to 95.9%.

    Gap Low · 7 → Medium · 20

    Progress is running ahead of attention.

    More facts
    Momentum: Very strong
    Material
  • 8-KFiled 3 Nov 2026All industries

    Driven Brands Holdings Inc.DRVN

    8-K · Items 2.02, 4.02 — Results of operations

    Driven Brands disclosed material errors in consolidated financial statements for fiscal years 2023–2025 and interim periods, primarily in fixed asset accounting. Restatement required; Q3 10-Q filing delayed. Adjusted EBITDA guidance lowered; restatement costs now ≥$50M.

    No notable change in AIR's read.

    More facts
    Momentum: Watch
    Material
  • 8-KFiled 3 Nov 2026Biotech

    Madrigal Pharmaceuticals, Inc.MDGL

    8-K · Item 2.02 — Results of operations

    Madrigal reported Q3 2026 net sales of $431.3M (50% YoY growth), achieved first profitability quarter with $55.4M net income, and Rezdiffra reached blockbuster status with $1.1B year-to-date sales. Patient count nearly doubled to 55,850.

    Gap Medium · 21 → High · 32

    Progress is running ahead of attention.

    The price trend weakened.

    More facts
    Momentum: Watch
    Material
  • 8-KFiled 3 Nov 2026Biotech

    Arvinas, Inc.ARVN

    8-K · Item 2.02 — Results of operations

    Arvinas reported Q3 2026 results with multiple clinical advances: initiated dosing in ARV-6723 Phase 1/2 trial, presented ARV-102 biomarker data showing oculomotor improvements in Parkinson's disease, and advanced ARV-393 and ARV-027 programs. Cash runway extended to H2 2028.

    Value: Balanced 57 → Strong 65Gap Low · 0 → Medium · 12

    The shares became cheaper on AIR's value read.

    Progress is running ahead of attention.

    The price trend weakened.

    More facts
    Momentum: Weak
    Material
  • 8-KFiled 3 Nov 2026Biotech

    Rhythm Pharmaceuticals, Inc.RYTM

    8-K · Item 2.02 — Results of operations

    Q3 2026 revenue of $92.1M (+29% QoQ) driven by IMCIVREE launch momentum (700+ patient starts). Japan launch underway. Bivamelagon advancing to Phase 3. $750M financing secured. Cash runway extended to 24+ months.

    Recognition: Balanced 56 → Strong 65Gap Medium · 24 → High · 27

    More of the market is starting to notice.

    Progress is running ahead of attention.

    The price trend strengthened.

    More facts
    Momentum: Balanced
    Material
  • 8-KFiled 3 Nov 2026All industries

    AdaptHealth Corp.AHCO

    8-K · Item 2.02 — Results of operations

    Q3 2026 revenue beat guidance at $745.6M (+10.9% YoY), but net loss of $168.2M driven by $184.8M goodwill write-down. Adjusted EBITDA declined 2.9% to $141.9M. Free cash flow guidance cut from $80–120M to $50–75M. Capitated contract improving; Diabetes Health sale cleared HSR.

    No notable change in AIR's read.

    More facts
    Momentum: Watch
    Material
  • 8-KFiled 3 Nov 2026Industrials

    BETA Technologies, Inc.BETA

    8-K · Item 2.02 — Results of operations

    Q3 2026 revenue of $17.7M exceeded guidance (98% YoY growth). Historic FAA market survey authorization for A250 electric VTOL aircraft. Backlog surpassed $4.0B. Full-year revenue guidance raised to $52–57M. Net loss ($119.1M) and Adjusted EBITDA ($97.4M) reflect heavy R&D investment.

    Recognition: Balanced 56 → Balanced 51Gap High · 40 → Very high · 53

    Market attention has faded.

    Progress is running ahead of attention.

    The price trend strengthened.

    More facts
    Momentum: Strong
    Material
  • 8-KFiled 3 Nov 2026Software / SaaS

    DigitalOcean Holdings, Inc.DOCN

    8-K · Items 2.02, 8.01 — Results of operations

    Q3 2026 revenue of $321M grew 40% YoY with record $160M ARR added. Company raised Q4 2026 guidance to 44-45% growth and 2027 outlook to 60%+ growth. Launched AI agent products and secured $785M equipment lease facility.

    Recognition: Balanced 46 → Watch 40Value: Weak 20 → Watch 28Gap Very high · 64 → Very high · 80

    Market attention has faded.

    The shares became cheaper on AIR's value read.

    Progress is running ahead of attention.

    The price trend weakened.

    More facts
    Momentum: Watch
    Material
  • 8-KFiled 3 Nov 2026All industries

    Flywire CorpFLYW

    8-K · Items 2.02, 5.02 — Results of operations

    Q3 2026 revenue grew 25.1% YoY to $250.3M, exceeding guidance. Adjusted EBITDA margin expanded 310 bps to 32.5%. FY2026 guidance raised on revenue growth and margin expansion. Strong payment volume growth of 27.7% and strategic client wins across all verticals.

    Value: Balanced 48 → Balanced 45Gap Low · 3 → High · 28

    The shares became dearer on AIR's value read.

    Progress is running ahead of attention.

    The price trend weakened.

    More facts
    Momentum: Strong
    Material
  • 8-KFiled 3 Nov 2026Industrials

    Transcat IncTRNS

    8-K · Item 2.02 — Results of operations

    Transcat reported Q2 FY2027 results with 18% total revenue growth to $97.1M, 23% service revenue growth, 220bps service margin expansion, and 23% adjusted EBITDA growth. Raised full-year service organic revenue guidance to low double digits from high single digits.

    Recognition: Balanced 53 → Balanced 58Gap High · 34 → High · 39

    More of the market is starting to notice.

    Progress is running ahead of attention.

    The price trend strengthened.

    More facts
    Momentum: Strong
    Material
  • 8-KFiled 3 Nov 2026Software / SaaS

    Duolingo, Inc.DUOL

    8-K · Item 2.02 — Results of operations

    Duolingo reported Q3 2026 results with DAU growth accelerating to 29% YoY, bookings and revenue beating expectations, and raised full-year guidance across all key metrics. Strong execution on strategy prioritizing user growth and teaching quality.

    Recognition: Strong 67 → Strong 75Value: Very strong 87 → Very strong 81Gap Low · 0 → Low · 6

    More of the market is starting to notice.

    The shares became dearer on AIR's value read.

    Progress is running ahead of attention.

    The price trend strengthened.

    More facts
    Momentum: Balanced
    Material
  • 8-KFiled 3 Nov 2026All industries

    Ouster, Inc.OUST

    8-K · Item 2.02 — Results of operations

    Ouster reported Q3 2026 revenue of $59M (50% YoY growth, 15th consecutive quarter of growth), shipped 27,000+ sensors, and improved net loss to $14M. Rev8 native color lidar gaining traction; Stereolabs acquisition driving record camera shipments in robotics sector.

    Gap Medium · 10 → Medium · 21

    Progress is running ahead of attention.

    More facts
    Momentum: Watch
    Material
  • 8-KFiled 3 Nov 2026Semiconductors

    Navitas Semiconductor CorpNVTS

    8-K · Item 2.02 — Results of operations

    Q3 2026 revenue grew 33% sequentially and 38% YoY to $14M. Company executing Navitas 2.0 transformation, exiting mobile/consumer markets while scaling AI infrastructure business (40%+ of revenue by year-end). Claros acquisition completed; Q4 guidance projects 14% sequential growth.

    Gap Very high · 49 → Very high · 58

    Progress is running ahead of attention.

    More facts
    Momentum: Weak
    Material
  • 8-KFiled 3 Nov 2026Biotech

    Corcept Therapeutics IncCORT

    8-K · Item 2.02 — Results of operations

    Q3 2026 revenue of $340.5M (+64% YoY), net income $126.8M (+544% YoY). Lifyorli launched April 2026 with 2,300+ patients treated. BELLA Part A ovarian cancer trial showed clinically meaningful PFS, ORR, and OS. Company reiterates $1.1–$1.2B 2026 guidance.

    Gap Low · 0 → Low · 8

    Progress is running ahead of attention.

    The price trend weakened.

    More facts
    Momentum: Balanced
    Material
  • 8-KFiled 3 Nov 2026Industrials

    Ufp Technologies IncUFPT

    8-K · Item 2.02 — Results of operations

    UFP Technologies reported Q3 2026 net income of $20.6M (25.8% YoY increase) and sales of $172.4M (11.6% growth). Nine-month net income rose 16.2% to $59.0M on 10.3% sales growth. Gross margins expanded and adjusted operating income grew 14.5% in Q3.

    No notable change in AIR's read.

    More facts
    Momentum: Strong
    Material
  • 8-KFiled 3 Nov 2026Banks

    LendingTree, Inc.TREE

    8-K · Item 2.02 — Results of operations

    Recognition: Watch 43 → Balanced 50

    More of the market is starting to notice.

    The price trend strengthened.

    More facts
    Momentum: Watch
    Material
  • 8-KFiled 3 Nov 2026All industries

    Limbach Holdings, Inc.LMB

    8-K · Item 2.02 — Results of operations

    Q3 2026 revenue hit record $230.5M (+24.9% YoY), driven by 14.4% organic growth and two acquisitions. Adjusted EBITDA rose 25.9% to $27.4M. Company raised FY2026 guidance to high end of range ($760–790M revenue, $78–84M Adj. EBITDA).

    Gap Very high · 89 → Very high · 92

    Progress is running ahead of attention.

    The price trend strengthened.

    More facts
    Momentum: Weak
    Material
  • 8-KFiled 3 Nov 2026All industries

    Community Healthcare Trust IncCHCT

    8-K · Item 2.02 — Results of operations

    CHCT reported Q3 2026 net income of $3.1M ($0.09/share), FFO of $0.54/share (up 8% YoY), and AFFO of $0.58/share (up 3.6% YoY). Company executing strategic plan with revenue growth of 4%, occupancy improvement to 90.1%, and $32.3M in property dispositions completed. Maintained $0.33 quarterly dividend.

    Gap Low · 0 → Medium · 14

    Progress is running ahead of attention.

    The price trend strengthened.

    More facts
    Momentum: Watch
    Material
  • 8-KFiled 3 Nov 2026Banks

    Upstart Holdings, Inc.UPST

    8-K · Item 2.02 — Results of operations

    Q3 2026 results show strong growth: originations up 44% YoY to $4.1B, revenue up 34% to $371M, net income up 15% to $36.6M. Record contribution profit of $218M. Secured products reached positive contribution margin ahead of schedule.

    Value: Weak 5 → Weak 13Gap Very high · 57 → Very high · 66

    The shares became cheaper on AIR's value read.

    Progress is running ahead of attention.

    More facts
    Momentum: Weak
    Material
  • 8-KFiled 3 Nov 2026All industries

    ADT Inc.ADT

    8-K · Item 2.02 — Results of operations

    ADT reported Q3 2026 results with 4% revenue growth to $1.3B, GAAP EPS up 18%, and adjusted free cash flow up 4%. Company announced pending acquisition by Thrive Holdings at $10/share in all-cash deal expected to close Q1 2027.

    Recognition: Balanced 53 → Balanced 56

    More of the market is starting to notice.

    The price trend strengthened.

    More facts
    Momentum: Strong
    Material
  • 8-KFiled 3 Nov 2026All industries

    SEADRILL LtdSDRL

    8-K · Item 2.02 — Results of operations

    Seadrill secured ~$800M in new contract awards across Indonesia, Malaysia, Angola, and U.S. Gulf. Raised full-year 2026 revenue guidance to $1.56–$1.58B and Adjusted EBITDA to $440–$460M. Generated $179M free cash flow in Q3; contract backlog now ~$3.3B with >85% of 2027 drillship days contracted.

    Recognition: Balanced 57 → Balanced 50Gap High · 25 → High · 39

    Market attention has faded.

    Progress is running ahead of attention.

    The price trend weakened.

    More facts
    Momentum: Balanced
    Material
  • 8-KFiled 3 Nov 2026All industries

    Nuveen Churchill Direct Lending Corp.NCDL

    8-K · Item 2.02 — Results of operations

    NCDL reported Q3 2026 NII of $0.38/share and declared Q4 distribution of $0.38/share ($0.36 regular + $0.02 supplemental). NAV declined slightly to $17.13 from $17.19. Portfolio stable at $1.9B; non-accrual rate unchanged at 1.5%. Joint Venture commenced operations.

    Recognition: Weak 23 → Watch 27

    More of the market is starting to notice.

    The price trend strengthened.

    More facts
    Momentum: Watch
    Material
  • 8-KFiled 3 Nov 2026Biotech

    Mirum Pharmaceuticals, Inc.MIRM

    8-K · Item 2.02 — Results of operations

    Q3 2026 net product sales of $185.7M exceeded guidance trajectory; full-year guidance raised to $715–720M. FDA approved ATEBRIOZ for FOP and granted orphan designation for brelovitug in HDV. Three positive Phase 3 readouts support upcoming regulatory submissions across LIVMARLI, ATEBRIOZ, and brelovitug.

    Gap Very high · 78 → Very high · 81

    Progress is running ahead of attention.

    The price trend strengthened.

    More facts
    Momentum: Watch
    Material
  • 8-KFiled 3 Nov 2026Software / SaaS

    Clarivate PLCCLVT

    8-K · Item 2.02 — Results of operations

    Clarivate completed Q3 2026 earnings with improved organic recurring revenue growth (0.7%), positive ACV growth in IP segment (1.8%), and early close of LS&H divestiture ($488.4M proceeds). Updated 2026 guidance reflects portfolio transformation toward higher-margin recurring revenue base.

    Recognition: Watch 31 → Watch 36Gap Very high · 71 → Very high · 74

    More of the market is starting to notice.

    Progress is running ahead of attention.

    The price trend strengthened.

    More facts
    Momentum: Watch
    Material
  • 8-KFiled 3 Nov 2026Software / SaaS

    Dynatrace, Inc.DT

    8-K · Items 2.02, 8.01 — Results of operations

    Dynatrace reported Q2 FY2027 results with 16% ARR growth to $2.21B and 17% revenue growth. Completed Arize acquisition, announced $1B share repurchase program, and guided FY2027 ARR growth upward by 150–200 bps. Investor Day scheduled for February 2027.

    Recognition: Very strong 88 → Strong 78Value: Watch 39 → Balanced 59Gap Low · 2 → Medium · 15

    Market attention has faded.

    The shares became cheaper on AIR's value read.

    Progress is running ahead of attention.

    The price trend weakened.

    More facts
    Momentum: Balanced
    Material
  • 8-KFiled 3 Nov 2026All industries

    First Watch Restaurant Group, Inc.FWRG

    8-K · Item 2.02 — Results of operations

    Q3 2026: Same-restaurant sales +1.0%, total revenue +10.7% to $349.9M, net income $4.8M, Adjusted EBITDA $39.7M. Opened 16 new restaurants. Raised full-year 2026 Adjusted EBITDA guidance to high end of range (~$136M).

    Recognition: Balanced 58 → Balanced 61Gap Low · 7 → Medium · 16

    More of the market is starting to notice.

    Progress is running ahead of attention.

    The price trend strengthened.

    More facts
    Momentum: Watch
    Material
  • 8-KFiled 3 Nov 2026Biotech

    Tarsus Pharmaceuticals, Inc.TARS

    8-K · Item 2.02 — Results of operations

    XDEMVY achieved record Q3 2026 net sales of $194.6M (+64% YoY). Company surpassed 1M bottles dispensed and $1B cumulative sales since launch. Pipeline advanced with multiple clinical milestones expected H1 2027. Two strategic acquisitions completed.

    Recognition: Strong 67 → Balanced 63Gap Very high · 87 → Very high · 91

    Market attention has faded.

    Progress is running ahead of attention.

    The price trend weakened.

    More facts
    Momentum: Balanced
    Material
  • 8-KFiled 3 Nov 2026All industries

    Cricut, Inc.CRCT

    8-K · Item 2.02 — Results of operations

    Cricut reported Q3 2026 revenue of $188.6M (+11% YoY), net income of $27.8M (+36% YoY), and 3.07M paid subscribers (+2% YoY). Gross margin expanded to 57.7% from 55.2%. Company approved recurring and special dividends plus $50M share repurchase authorization.

    Recognition: Balanced 57 → Balanced 63Gap Low · 0 → Medium · 10

    More of the market is starting to notice.

    Progress is running ahead of attention.

    The price trend strengthened.

    More facts
    Momentum: Very strong
    Material
  • 8-KFiled 3 Nov 2026All industries

    UL Solutions Inc.ULS

    8-K · Item 2.02 — Results of operations

    Q3 2026: Revenue $823M (+5.1% YoY, 7.0% organic), Net Income $117M (+10.4%), Adjusted EBITDA $235M (+8.3%, 28.6% margin +90bps). Raised FY2026 organic revenue guidance to ~6.5%. Completed $686M Eurofins E&E acquisition.

    Gap Low · 0 → Low · 4

    Progress is running ahead of attention.

    The price trend strengthened.

    More facts
    Momentum: Watch
    Material
  • 8-KFiled 3 Nov 2026Biotech

    QuidelOrtho CorpQDEL

    8-K · Items 2.02, 5.02 — Results of operations

    Q3 2026 revenue declined 12% YoY to $619M; GAAP net loss $54M. Company initiated $80M+ cost-reduction restructuring with $30–35M one-time charges. Full-year EPS guidance narrowed significantly downward.

    Recognition: Balanced 56 → Balanced 60

    More of the market is starting to notice.

    The price trend strengthened.

    More facts
    Momentum: Watch
    Material

Monday 2 Nov71 filings read · 71 material

  • 8-KFiled 2 Nov 2026All industries

    Choice Hotels International Inc /DeCHH

    8-K · Item 2.02 — Results of operations

    Q3 2026 results show improving fundamentals: U.S. net rooms growth stabilized, RevPAR up 3.8%, adjusted EBITDA +1% YoY, and full-year RevPAR/EBITDA guidance raised. Company advancing asset-light strategy via hotel sales while acquiring Harvest Hosts.

    Recognition: Balanced 62 → Strong 65Gap Low · 3 → Medium · 11

    More of the market is starting to notice.

    Progress is running ahead of attention.

    The price trend strengthened.

    More facts
    Momentum: Strong
    Material
  • 8-KFiled 2 Nov 2026Biotech

    Biomarin Pharmaceutical IncBMRN

    8-K · Item 2.02 — Results of operations

    Q3 2026 revenue beat at $1.025B (+32% YoY), but full-year guidance reduced significantly. Non-GAAP EPS guidance cut from $4.90–$5.10 to $2.80–$3.10 (−43% midpoint) due to $320M Alesta IPR&D charges and $83M BMN 450 license costs.

    Gap Very high · 63 → Very high · 59

    The gap narrowed as the filings read less positively.

    The price trend weakened.

    More facts
    Momentum: Balanced
    Material
  • 8-KFiled 2 Nov 2026All industries

    Herbalife Ltd.HLF

    8-K · Item 2.02 — Results of operations

    Herbalife reported Q3 2026 net sales of $1.35B (+6.0% YoY), beating guidance with adjusted EBITDA of $182.4M (+70 bps margin). Fifth consecutive quarter of growth; full-year sales guidance raised. New $250M share repurchase program authorized.

    Recognition: Balanced 45 → Balanced 49Gap High · 43 → Very high · 49

    More of the market is starting to notice.

    Progress is running ahead of attention.

    The price trend strengthened.

    More facts
    Momentum: Balanced
    Material
  • 8-KFiled 2 Nov 2026All industries

    Tetra Technologies IncTTI

    8-K · Item 2.02 — Results of operations

    Gap Very high · 51 → Very high · 62

    Progress is running ahead of attention.

    The price trend strengthened.

    More facts
    Momentum: Weak
    Material
  • 8-KFiled 2 Nov 2026Biotech

    Syndax Pharmaceuticals IncSNDX

    8-K · Items 2.02, 5.02 — Results of operations

    Syndax reported Q3 2026 revenue of $83.3M (82% YoY growth), driven by Revuforj ($60.7M, 90% YoY) and Niktimvo collaboration revenue ($22.6M, 47% YoY). New patient uptake accelerated 20% QoQ. CFO transition announced with experienced replacement.

    Gap Very high · 47 → Very high · 68

    Progress is running ahead of attention.

    The price trend weakened.

    More facts
    Momentum: Weak
    Material
  • 8-KFiled 2 Nov 2026All industries

    Adeia Inc.ADEA

    8-K · Item 2.02 — Results of operations

    Value: Watch 41 → Balanced 52Gap Low · 4 → Medium · 16

    The shares became cheaper on AIR's value read.

    Progress is running ahead of attention.

    The price trend weakened.

    More facts
    Momentum: Watch
    Material
  • 8-KFiled 2 Nov 2026Industrials

    Napco Security Technologies, IncNSSC

    8-K · Item 2.02 — Results of operations

    NAPCO reported Q1 FY2027 record revenue of $50.0M (+1.7% YoY) and record net income of $13.0M (+6.9% YoY). Recurring service revenue hit record $26.1M (+11.5%) with 90%+ margins and ~$106M annualized run rate. Board declared $0.17/share dividend.

    Gap Medium · 13 → High · 27

    Progress is running ahead of attention.

    The price trend weakened.

    More facts
    Momentum: Weak
    Material
  • 8-KFiled 2 Nov 2026Biotech

    CRISPR Therapeutics AGCRSP

    8-K · Item 2.02 — Results of operations

    CRSP reported Q3 2026 CASGEVY revenue of $99M (30% QoQ growth, 6x YoY), expanded pediatric approvals across multiple countries, received FDA RMAT designations for CTX310 in two indications, and completed Phase 2 enrollment for CTX611. Pipeline advancing across multiple modalities.

    Gap Medium · 18 → High · 25

    Progress is running ahead of attention.

    The price trend weakened.

    More facts
    Momentum: Watch
    Material
  • 8-KFiled 2 Nov 2026All industries

    Corebridge Financial, Inc.CRBG

    8-K · Item 2.02 — Results of operations

    Q3 2026 net income of $1.4B ($3.22 EPS) vs. $144M prior year, driven by favorable realized gains. Operating earnings $1.22 EPS (+27% YoY). Premiums/deposits $8.8B. Merger with Equitable advancing with $100M+ synergies identified. Returned $295M to shareholders.

    Value: Balanced 64 → Balanced 61Gap Medium · 24 → High · 34

    The shares became dearer on AIR's value read.

    Progress is running ahead of attention.

    More facts
    Momentum: Strong
    Material
  • 8-KFiled 2 Nov 2026All industries

    Paymentus Holdings, Inc.PAY

    8-K · Item 2.02 — Results of operations

    Paymentus reported Q3 2026 revenue of $372.2M (+19.8% YoY), with contribution profit up 20.6% and adjusted EBITDA up 38.6% to record 41.9% margin. Net income increased 55% YoY. Company reaffirmed 2026 guidance and expressed confidence in 2027 outlook.

    Gap High · 39 → Very high · 48

    Progress is running ahead of attention.

    The price trend strengthened.

    More facts
    Momentum: Balanced
    Material
  • 8-KFiled 2 Nov 2026All industries

    Atlas Energy Solutions Inc.AESI

    8-K · Item 2.02 — Results of operations

    Q3 2026 revenue $267.8M with $30.3M Adjusted EBITDA. Company secured two Cost Reimbursement Agreements for 283 MW data center projects and closed $424M bridge facility. Positioned with 23M+ allocated tons for 2027.

    No notable change in AIR's read.

    More facts
    Momentum: Weak
    Material
  • 8-KFiled 2 Nov 2026Biotech

    Krystal Biotech, Inc.KRYS

    8-K · Item 2.02 — Results of operations

    Q3 2026 revenue of $127.3M (+30% YoY) with 94% gross margin. KB113 shows >80% BCC regression in Gorlin syndrome. $1.2B cash position. Board authorizes $400M share repurchase program.

    Recognition: Balanced 60 → Balanced 56Gap Low · 4 → Medium · 15

    Market attention has faded.

    Progress is running ahead of attention.

    The price trend weakened.

    More facts
    Momentum: Balanced
    Material
  • 8-KFiled 2 Nov 2026Industrials

    Cerus CorpCERS

    8-K · Item 2.02 — Results of operations

    Q3 2026 product revenue grew 10% YoY to $57.7M; IFC volumes surged ~80% YoY. Positive Phase 3 RedeS topline results announced for INTERCEPT RBC system. Company reiterates full-year 2026 product revenue guidance of $229–$231M (11–12% growth).

    Recognition: Watch 43 → Watch 39Gap Low · 5 → Medium · 20

    Market attention has faded.

    Progress is running ahead of attention.

    The price trend weakened.

    More facts
    Momentum: Balanced
    Material
  • 8-KFiled 2 Nov 2026All industries

    CenterspaceCSR

    8-K · Item 2.02 — Results of operations

    Q3 2026 earnings show Core FFO down 6.7% YoY to $1.11/share; same-store NOI declined 2.7% despite flat revenues as expenses rose 4.2%. Company disposed of 13 properties for $288.8M and reduced debt, but pending IRT merger eliminates forward guidance.

    Gap Very high · 50 → High · 41

    The gap narrowed — attention is catching up.

    More facts
    Momentum: Balanced
    Material
  • 8-KFiled 2 Nov 2026Industrials

    Harmonic Inc.HLIT

    8-K · Item 2.02 — Results of operations

    Harmonic reported Q3 2026 revenue of $148.8M, 64% YoY growth well above guidance. Rest-of-Market revenue more than doubled. Company raised full-year 2026 revenue outlook to $545–$555M. Backlog increased 58% to $534M.

    Gap Very high · 54 → Very high · 62

    Progress is running ahead of attention.

    More facts
    Momentum: Watch
    Material
  • 8-KFiled 2 Nov 2026All industries

    Cna Financial CorpCNA

    8-K · Item 2.02 — Results of operations

    Q3 2026 core income of $203M ($0.75/share) declined 50% YoY from $409M ($1.50/share). P&C core income fell $59M; Life & Group posted $171M loss vs. $22M prior year, driven by unfavorable LTC reserve assumption updates of $137M after-tax.

    No notable change in AIR's read.

    More facts
    Momentum: Balanced
    Material
  • 8-KFiled 2 Nov 2026All industries

    Clorox Co /De/CLX

    8-K · Item 2.02 — Results of operations

    Clorox reported Q1 FY2027 results beating expectations with 33% net sales growth and 114% diluted EPS growth, driven by GOJO acquisition and strong cost savings. However, updated FY2027 outlook reflects higher inflationary pressures, with adjusted EPS expected at low end of range.

    Recognition: Strong 69 → Strong 77Value: Watch 44 → Watch 26Gap Low · 5 → Low · 9

    More of the market is starting to notice.

    The shares became dearer on AIR's value read.

    Progress is running ahead of attention.

    The price trend strengthened.

    More facts
    Momentum: Watch
    Material
  • 8-KFiled 2 Nov 2026All industries

    Tennant CoTNC

    8-K · Item 2.02 — Results of operations

    Tennant reported Q3 2026 net sales of $322.3M (+6.2% YoY) with strong order growth (+9.5%) and robotics momentum (+71% sales). Adjusted EBITDA declined slightly to $48.8M but improved sequentially. Full-year guidance reaffirmed despite margin pressures from inflation and supply constraints.

    Recognition: Balanced 47 → Balanced 50Gap Low · 0 → Medium · 11

    More of the market is starting to notice.

    Progress is running ahead of attention.

    The price trend strengthened.

    More facts
    Momentum: Watch
    Material
  • 8-KFiled 2 Nov 2026All industries

    Capital Southwest CorpCSWC

    8-K · Item 2.02 — Results of operations

    CSWC reported Q2 FY2027 results with record $391M originations across 30 portfolio companies, $0.58 pre-tax NII per share, and $0.64 total dividends. Portfolio quality stable at 1.4% non-accruals. Raised $350M debt and $67M equity; SBIC II leverage increased to $250M.

    Recognition: Balanced 54 → Balanced 47Gap Very high · 48 → Very high · 62

    Market attention has faded.

    Progress is running ahead of attention.

    The price trend strengthened.

    More facts
    Momentum: Balanced
    Material
  • 8-KFiled 2 Nov 2026All industries

    Diversified Healthcare TrustDHC

    8-K · Item 2.02 — Results of operations

    Q3 2026 results show strong operational momentum: same-property NOI up 25.6% YoY, SHOP occupancy +200 bps to 84.4%, average rates +5.2%, and Normalized FFO up to $0.13/share. Completed SNF transition generating $8M annual rent with reduced capex.

    Recognition: Watch 36 → Watch 30Gap Low · 0 → Medium · 17

    Market attention has faded.

    Progress is running ahead of attention.

    The price trend weakened.

    More facts
    Momentum: Balanced
    Material
  • 8-KFiled 2 Nov 2026All industries

    Ethos Technologies Inc.LIFE

    8-K · Item 2.02 — Results of operations

    Ethos reported Q3 2026 revenue of $235.2M (+151% YoY), third consecutive quarter of triple-digit growth. Achieved profitability with $4.7M net income and $33.8M non-GAAP net income. Activated 142K new policies (+189% YoY). FY2026 guidance raised to $838–842M revenue (+117% YoY).

    Gap Low · 0 → Low · 8

    Progress is running ahead of attention.

    The price trend weakened.

    More facts
    Momentum: Balanced
    Material
  • 8-KFiled 2 Nov 2026Biotech

    Emergent BioSolutions Inc.EBS

    8-K · Item 2.02 — Results of operations

    Q3 2026 revenues of $110.0M (52% YoY decline) with net loss of $32.7M and adjusted EBITDA loss of $4.6M. Significant declines across naloxone, smallpox MCM, and other products driven by unfavorable pricing, volume mix, and government purchase timing.

    No notable change in AIR's read.

    More facts
    Momentum: Weak
    Material
  • 8-KFiled 2 Nov 2026All industries

    Equitable Holdings, Inc.EQH

    8-K · Item 2.02 — Results of operations

    EQH reported Q3 2026 net income of $1.1B ($4.05/share) vs. prior-year loss, with Non-GAAP operating EPS of $2.13 (up 19% YoY). Strong organic growth across all segments: $1.1B Retirement inflows, $2.7B Wealth Management advisory inflows, $6.6B Asset Management inflows. Corebridge merger on track for year-end close.

    Gap High · 27 → High · 40

    Progress is running ahead of attention.

    More facts
    Momentum: Strong
    Material
  • 8-KFiled 2 Nov 2026All industries

    BOISE CASCADE CoBCC

    8-K · Item 2.02 — Results of operations

    Q3 2026 net income of $36.4M ($1.04/share) on $1.8B sales, up 67% and 79% YoY respectively. Wood Products swung to $16.1M profit from $12.1M loss. Adjusted EBITDA +32% to $98.5M despite softer housing starts.

    Gap Low · 6 → Medium · 20

    Progress is running ahead of attention.

    More facts
    Momentum: Balanced
    Material
  • 8-KFiled 2 Nov 2026All industries

    UDR, Inc.UDR

    8-K · Item 2.02 — Results of operations

    UDR raised full-year 2026 guidance for Net Income, FFOA, and Same-Store growth after Q3 results exceeded expectations. Closed $2.0B Apollo partnership, repurchased $185M in shares, and achieved 1.6% YTD same-store NOI growth with strong occupancy.

    Gap Medium · 11 → Medium · 18

    Progress is running ahead of attention.

    The price trend strengthened.

    More facts
    Momentum: Balanced
    Material
  • 8-KFiled 2 Nov 2026Software / SaaS

    Match Group, Inc.MTCH

    8-K · Items 2.02, 8.01 — Results of operations

    Match Group reported Q3 2026 results showing Tinder's turnaround gaining traction: DAU returned to Y/Y growth in September after 3.5 years of decline; Sparks and Sparks Coverage hit strongest quarterly Y/Y performance; Hinge delivered double-digit user, revenue, and payer growth. Board declared $0.20/share dividend.

    Value: Strong 74 → Strong 78Gap Low · 0 → Medium · 19

    The shares became cheaper on AIR's value read.

    Progress is running ahead of attention.

    More facts
    Momentum: Strong
    Material
  • 8-KFiled 2 Nov 2026All industries

    Acadia Realty TrustAKR

    8-K · Item 2.02 — Results of operations

    Q3 2026: Same-property NOI grew 10.2% (street retail +15.2%), FFO As Adjusted up 6.9% YoY to $0.31/share. Signed-not-open pipeline grew 32% to $21.8M. Completed $152M accretive acquisitions. Maintained FFO guidance but revised net earnings guidance down due to $11.7M impairment charge.

    Gap High · 35 → Very high · 47

    Progress is running ahead of attention.

    The price trend strengthened.

    More facts
    Momentum: Watch
    Material
  • 8-KFiled 2 Nov 2026All industries

    Vornado Realty TrustVNO

    8-K · Item 2.02 — Results of operations

    Q3 2026: Net loss of $47.1M vs. prior-year income of $11.6M. FFO adjusted grew 14% YoY to $0.65/share. Major positive: 350 Park Avenue joint venture with Citadel as anchor tenant; estimated $485M gain in Q4. Challenges include maturity defaults at 825 Seventh Avenue and 888 Seventh Avenue.

    Gap Medium · 18 → Low · 4

    The gap narrowed as the filings read less positively.

    More facts
    Momentum: Watch
    Material
  • 8-KFiled 2 Nov 2026All industries

    Metallus Inc.MTUS

    8-K · Item 2.02 — Results of operations

    Q3 2026 net sales $337.2M (+10% YoY), net income $23.8M (+194% YoY). Adjusted EBITDA $34.5M (+19% YoY/sequential). Awarded DLA contract with $125M initial PO and up to $995M over 5 years. Strong aerospace & defense momentum.

    Recognition: Balanced 56 → Balanced 47Gap Low · 4 → Medium · 17

    Market attention has faded.

    Progress is running ahead of attention.

    The price trend weakened.

    More facts
    Momentum: Watch
    Material
  • 8-KFiled 2 Nov 2026All industries

    Cabot CorpCBT

    8-K · Item 2.02 — Results of operations

    Cabot reported Q4 FY2026 Adjusted EPS of $1.61 and full-year $6.42, with strong Performance Chemicals segment performance. Secured $50M DOE grant for battery materials expansion in Louisiana and Texas. Battery Materials achieved $43M EBITDA, a new high.

    Gap Low · 0 → Medium · 11

    Progress is running ahead of attention.

    More facts
    Momentum: Watch
    Material
  • 8-KFiled 2 Nov 2026Biotech

    Recursion Pharmaceuticals, Inc.RXRX

    8-K · Items 2.02, 5.02 — Results of operations

    Recursion reported positive Phase 2 REC-4881 data in FAP showing deep, durable polyp reductions across GI tract; REC-1245 early signals in endometrial cancer; Sanofi optioned first development candidate ($10M milestone); cash runway extended to 2029; Fred Hassan appointed Board Chair.

    Value: Balanced 61 → Strong 65Gap Very high · 54 → Very high · 73

    The shares became cheaper on AIR's value read.

    Progress is running ahead of attention.

    The price trend weakened.

    More facts
    Momentum: Balanced
    Material
  • 8-KFiled 2 Nov 2026All industries

    V2X, Inc.VVX

    8-K · Item 2.02 — Results of operations

    V2X reported Q3 2026 revenue of $1.27B (+9% YoY), net income up 30% YoY, and diluted EPS up 32% YoY. Company raised full-year 2026 guidance across all metrics. Strong backlog of $12.8B and improved leverage position.

    Recognition: Balanced 62 → Balanced 57Gap Low · 3 → Medium · 14

    Market attention has faded.

    Progress is running ahead of attention.

    The price trend weakened.

    More facts
    Momentum: Balanced
    Material
  • 8-KFiled 2 Nov 2026All industries

    AH Realty Trust, Inc.AHRT

    8-K · Item 2.02 — Results of operations

    Q3 2026 results show strong operational performance with retail and office same-store NOI growth of 6.8% and 5.2% respectively. Company raised full-year FFO guidance by 11.5% to $0.57–$0.59/share, driven by better-than-expected leasing, debt paydowns, and operational efficiencies.

    Recognition: Watch 38 → Watch 41Gap Low · 7 → Medium · 20

    More of the market is starting to notice.

    Progress is running ahead of attention.

    The price trend strengthened.

    More facts
    Momentum: Balanced
    Material
  • 8-KFiled 2 Nov 2026Biotech

    CorMedix Inc.CRMD

    8-K · Item 2.02 — Results of operations

    CMS approved DefenCath 2027 Q1 Add-on of $8.32/session (3-5x higher than current $2.37). Company reaffirms 2026 revenue guidance of $325-345M and reports $355M cash. Full-year 2027 Add-on expected to average >2x current rate.

    Gap High · 42 → Very high · 50

    Progress is running ahead of attention.

    More facts
    Momentum: Weak
    Material
  • 8-KFiled 2 Nov 2026All industries

    Entergy Arkansas, LLCEAI

    8-K · Item 2.02 — Results of operations

    Entergy reported Q3 2026 EPS of $1.98, beating prior year by $0.45. Company narrowed 2026 guidance to $4.35–$4.45. Key wins: Google service expansion, transmission project approval, resilience plan settlements, $14M DOE grants, 6% dividend increase.

    Gap Low · 6 → High · 25

    Progress is running ahead of attention.

    More facts
    Momentum: Watch
    Material
  • 8-KFiled 2 Nov 2026All industries

    Celanese CorpCE

    8-K · Item 2.02 — Results of operations

    Celanese reported Q3 2026 earnings exceeding guidance with adjusted EPS of $1.65, net sales growth of 6% YoY, and strong free cash flow of $461M. Company raised full-year adjusted EPS guidance to $6.00–$6.25 and increased free cash flow outlook to $750–$800M.

    No notable change in AIR's read.

    More facts
    Momentum: Balanced
    Material
  • 8-KFiled 2 Nov 2026Industrials

    SI-BONE, Inc.SIBN

    8-K · Item 2.02 — Results of operations

    Q3 2026 revenue grew 14.5% YoY to $55.7M with 20% U.S. procedure volume growth. Net loss improved 20.7%. FDA cleared iFuse Granite Onyx (breakthrough device, ~$1.5B TAM). New MS-DRGs effective October increase hospital payments ~$50K per qualifying procedure. Company reaffirms 2026 guidance.

    No notable change in AIR's read.

    More facts
    Momentum: Very strong
    Material
  • 8-KFiled 2 Nov 2026All industries

    Sabra Health Care REIT, Inc.SBRA

    8-K · Item 2.02 — Results of operations

    Sabra reported Q3 2026 results with FFO of $0.40/share and raised full-year guidance. Same-store SHOP Cash NOI grew 14.6% YoY. Company closed $222.8M in acquisitions and has $425M awarded. Leverage improved to 4.54x Net Debt/EBITDA.

    Gap Low · 0 → Low · 9

    Progress is running ahead of attention.

    The price trend strengthened.

    More facts
    Momentum: Balanced
    Material
  • 8-KFiled 2 Nov 2026All industries

    Transocean Ltd.RIG

    8-K · Item 2.02 — Results of operations

    Recognition: Very strong 82 → Strong 74Value: Balanced 61 → Strong 72Gap Medium · 22 → High · 34

    Market attention has faded.

    The shares became cheaper on AIR's value read.

    Progress is running ahead of attention.

    The price trend weakened.

    More facts
    Momentum: Balanced
    Material
  • 8-KFiled 2 Nov 2026Industrials

    Inspire Medical Systems, Inc.INSP

    8-K · Item 2.02 — Results of operations

    Q3 2026 revenue declined 7.9% YoY to $206.7M due to coding/reimbursement headwinds. Net loss of $24.4M. FY2026 guidance narrowed to $850–860M. Offset partially by new CPT code approval (effective Jan 2028) and positive operating cash flow of $46.4M.

    No notable change in AIR's read.

    More facts
    Momentum: Balanced
    Material
  • 8-KFiled 2 Nov 2026All industries

    Chemours CoCC

    8-K · Item 2.02 — Results of operations

    Chemours reported Q3 2026 net sales of $1.5B (up 3% YoY) with net income of $196M ($1.29 EPS). Adjusted EBITDA grew 6% to $200M, driven by 10% TT pricing gains and 26% APM Performance Solutions growth. Settled PFAS litigation with North Carolina.

    No notable change in AIR's read.

    More facts
    Momentum: Watch
    Material
  • 8-KFiled 2 Nov 2026Software / SaaS

    Upwork, IncUPWK

    8-K · Items 2.02, 5.02 — Results of operations

    Q3 2026: Revenue $185.6M, GAAP net income $31.8M (+8% YoY), adjusted EBITDA $63.8M (+7% YoY). Lifted acquired WorkMotion EOR. MCP server adoption surged 20x; AI-skills GSV grew 55% YoY. CFO transition announced.

    Recognition: Watch 43 → Balanced 46Value: Very strong 85 → Very strong 82Gap Low · 0 → Medium · 19

    More of the market is starting to notice.

    The shares became dearer on AIR's value read.

    Progress is running ahead of attention.

    The price trend strengthened.

    More facts
    Momentum: Watch
    Material
  • 8-KFiled 2 Nov 2026Software / SaaS

    Hinge Health, Inc.HNGE

    8-K · Items 2.02, 5.02 — Results of operations

    Q3 2026 revenue grew 52% YoY to $235M; GAAP operating income $50.3M vs. loss of $6.1M YoY. FY2026 guidance raised to $880M revenue (50% growth) and 30% non-GAAP operating margin. Free cash flow $113M with 48% margin.

    Gap Low · 3 → Medium · 17

    Progress is running ahead of attention.

    More facts
    Momentum: Very strong
    Material
  • 8-KFiled 2 Nov 2026All industries

    Healthpeak Properties, Inc.DOC

    8-K · Item 2.02 — Results of operations

    Healthpeak reported Q3 2026 results with FFO as Adjusted of $0.44/share and raised full-year FFO guidance to $1.76–$1.78 (midpoint +$0.02). Strong leasing activity across outpatient medical and lab segments; Janus Living showed 78% revenue and 101% Adjusted EBITDAre growth YoY.

    Gap Low · 0 → Low · 9

    Progress is running ahead of attention.

    The price trend strengthened.

    More facts
    Momentum: Balanced
    Material
  • 8-KFiled 2 Nov 2026All industries

    New Mountain Finance CorpNMFC

    8-K · Item 2.02 — Results of operations

    Q3 2026 adjusted NII of $0.26/share matched prior year, but NAV declined to $10.67 from $10.89. Portfolio quality remains strong (86% green-rated), though net realized/unrealized losses of $19.95M in Q3 pressured results. Dividend maintained at $0.25/share.

    No notable change in AIR's read.

    More facts
    Momentum: Watch
    Material
  • 8-KFiled 2 Nov 2026Biotech

    Travere Therapeutics, Inc.TVTX

    8-K · Item 2.02 — Results of operations

    TVTX reported Q3 2026 FILSPARI net sales of $200M (120% YoY growth), 1,932 new patient starts, and advancing pipeline programs including Phase 3 pegtibatinase and civorebrutinib IND submission by year-end.

    Gap High · 33 → High · 40

    Progress is running ahead of attention.

    More facts
    Momentum: Balanced
    Material
  • 8-KFiled 2 Nov 2026Software / SaaS

    Healthstream IncHSTM

    8-K · Items 2.02, 8.01 — Results of operations

    Q3 2026 revenues grew 8.9% YoY to $83.3M; operating income declined 13% but adjusted EBITDA rose 1%. Company raised full-year 2026 guidance across revenue, net income, and adjusted EBITDA. Received $40M capital injection via private placement.

    Gap Very high · 53 → Very high · 66

    Progress is running ahead of attention.

    More facts
    Momentum: Strong
    Material
  • 8-KFiled 2 Nov 2026Semiconductors

    Ichor Holdings, Ltd.ICHR

    8-K · Item 2.02 — Results of operations

    Q3 2026 revenue of $328.7M (+37% YoY, +12% QoQ) with gross margin expansion to 15.8% GAAP and net income of $20.9M ($0.55 EPS). Q4 2026 guidance projects $345–365M revenue with $0.50–0.60 GAAP EPS, indicating continued sequential growth.

    Gap Low · 3 → Medium · 18

    Progress is running ahead of attention.

    More facts
    Momentum: Watch
    Material
  • 8-KFiled 2 Nov 2026Industrials

    Aehr Test SystemsAEHR

    8-K · Item 2.02 — Results of operations

    Aehr Test Systems reported record Q1 FY2027 revenue of $33.0M (200% YoY, 75% sequential growth), GAAP net income of $7.2M vs. prior-year loss, and raised full-year FY2027 revenue guidance to $150M (triple FY2026). Strong bookings of $46.7M and effective backlog of $109.3M.

    Gap Low · 3 → Medium · 18

    Progress is running ahead of attention.

    More facts
    Momentum: Watch
    Material
  • 8-KFiled 2 Nov 2026All industries

    Innovative Industrial Properties IncIIPR

    8-K · Item 2.02 — Results of operations

    Q3 2026: AFFO per share up 7% QoQ to $1.96; $275M accretive investment activity including $245M mezzanine loan at Alewife Park life science campus and $30M IQHQ preferred equity. Portfolio re-leasing momentum continues; dividend maintained at $1.90/share.

    No notable change in AIR's read.

    More facts
    Momentum: Balanced
    Material
  • 8-KFiled 2 Nov 2026All industries

    Calix, IncCALX

    8-K · Item 2.02 — Results of operations

    Calix reported Q3 2026 record revenue of $301.7M (+14% YoY, +3% QoQ), record software/service revenue of $51.9M (+19% YoY), and record RPOs of $395.7M (+12% YoY). Calix One contracts more than doubled QoQ. Full-year 2026 revenue guidance implies ~19% growth.

    Value: Watch 36 → Watch 40Gap Low · 4 → Medium · 16

    The shares became cheaper on AIR's value read.

    Progress is running ahead of attention.

    The price trend weakened.

    More facts
    Momentum: Weak
    Material
  • 8-KFiled 2 Nov 2026Banks

    Cipher Digital Inc.CIFR

    8-K · Item 2.02 — Results of operations

    Cipher Digital achieved first HPC lease revenue at Black Pearl, expanded Barber Lake lease to 20 years adding $5.2B incremental contracted revenue (total $9.1B), received conditional base load classification for 1 GW at Colchis, and commenced lateral pipeline development for 2.5 GW on-site generation capacity.

    No notable change in AIR's read.

    More facts
    Momentum: Weak
    Material
  • 8-KFiled 2 Nov 2026Software / SaaS

    Waystar Holding Corp.WAY

    8-K · Item 2.02 — Results of operations

    Waystar reported Q3 2026 revenue of $325.6M (+21% YoY), net income of $31.0M, and adjusted EBITDA margin of 43%. Subscription revenue grew 34% YoY. Full-year 2026 guidance raised to $1.277–$1.287B revenue and $543–$549M adjusted EBITDA.

    Gap High · 28 → High · 38

    Progress is running ahead of attention.

    The price trend strengthened.

    More facts
    Momentum: Balanced
    Material
  • 8-KFiled 2 Nov 2026Biotech

    Neurocrine Biosciences IncNBIX

    8-K · Item 2.02 — Results of operations

    Q3 2026 revenue grew 41% YoY to $1.1B, exceeding $1B for first time. INGREZZA guidance raised to $2.9–$2.925B. Strong product sales across INGREZZA, CRENESSITY, and VYKAT XR; multiple clinical milestones ahead.

    Recognition: Strong 70 → Strong 74

    More of the market is starting to notice.

    The price trend strengthened.

    More facts
    Momentum: Balanced
    Material
  • 8-KFiled 2 Nov 2026Industrials

    Tactile Systems Technology IncTCMD

    8-K · Item 2.02 — Results of operations

    Q3 2026 revenue grew 7% YoY to $91.9M with lymphedema segment up 13%. Gross margin expanded to 77%. Net income declined to $7.2M from $8.2M due to higher operating expenses. FY2026 Adjusted EBITDA guidance raised to $50-52M.

    Recognition: Watch 31 → Watch 38Value: Watch 44 → Watch 37Gap Low · 8 → Medium · 21

    More of the market is starting to notice.

    The shares became dearer on AIR's value read.

    Progress is running ahead of attention.

    The price trend strengthened.

    More facts
    Momentum: Balanced
    Material
  • 8-KFiled 2 Nov 2026All industries

    Huntsman CORPHUN

    8-K · Item 2.02 — Results of operations

    Huntsman reported Q3 2026 net loss of $18M vs. $25M prior year, with adjusted net income of $7M vs. loss of $5M. Adjusted EBITDA improved to $132M from $94M. Merger with Olin approved and regulatory clearance obtained; expected close Q1 2027.

    Gap Medium · 22 → High · 33

    Progress is running ahead of attention.

    The price trend strengthened.

    More facts
    Momentum: Watch
    Material
  • 8-KFiled 2 Nov 2026Industrials

    MSA Safety IncMSA

    8-K · Item 2.02 — Results of operations

    MSA Safety reported Q3 2026 net sales of $536M (15% GAAP, 6% organic growth). Adjusted EPS increased 8% YoY to $2.09. Company completed $563M Autronica acquisition, launched G1 City Edition SCBA, and achieved largest MSA+ order. Maintains full-year low-double-digit growth outlook.

    Value: Balanced 50 → Balanced 53Gap Medium · 12 → Medium · 21

    The shares became cheaper on AIR's value read.

    Progress is running ahead of attention.

    The price trend weakened.

    More facts
    Momentum: Balanced
    Material
  • 8-KFiled 2 Nov 2026Biotech

    Jazz Pharmaceuticals plcJAZZ

    8-K · Item 2.02 — Results of operations

    Jazz Pharmaceuticals reported Q3 2026 revenues of $1.2B (+10% YoY), raised full-year guidance to $4.775–$4.85B, achieved FDA approval and rapid Ziihera launch in HER2+ GEA, and closed Actio acquisition adding ABS-1230 to rare epilepsy portfolio.

    Gap Medium · 13 → Medium · 20

    Progress is running ahead of attention.

    The price trend strengthened.

    More facts
    Momentum: Balanced
    Material
  • 8-KFiled 2 Nov 2026Industrials

    FabrinetFN

    8-K · Item 2.02 — Results of operations

    Fabrinet reported record Q1 FY2027 revenue of $1,474.5M (+51% YoY), exceeding guidance. Non-GAAP EPS of $4.34 beat expectations. Board expanded share repurchase authorization by $103M. Q2 guidance projects continued strong performance.

    Value: Watch 33 → Watch 30Gap Very high · 45 → Very high · 52

    The shares became dearer on AIR's value read.

    Progress is running ahead of attention.

    More facts
    Momentum: Weak
    Material
  • 8-KFiled 2 Nov 2026Industrials

    Hillman Solutions Corp.HLMN

    8-K · Item 2.02 — Results of operations

    Recognition: Balanced 52 → Balanced 55Gap Very high · 78 → Very high · 74

    The gap narrowed — attention is catching up.

    The price trend strengthened.

    More facts
    Momentum: Balanced
    Material
  • 8-KFiled 2 Nov 2026Industrials

    National Presto Industries IncNPK

    8-K · Item 2.02 — Results of operations

    Q3 2026 net sales increased 25% YoY to $144.3M; net earnings surged 276% to $20.0M. Defense segment sales up 31.3%, earnings up 61.8%. Housewares returned to profitability ($8.1M) aided by tariff refund.

    Gap Low · 3 → Medium · 16

    Progress is running ahead of attention.

    More facts
    Momentum: Strong
    Material

Research, not tips. Filings come from SEC EDGAR; AIR's read is recomputed every trading day. A price move is shown as a fact beside a filing, never as the reason it is listed.